Incidence, Long-Term Outcomes, and Healthcare Utilization of Patients With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Disseminated Mycobacterium avium Complex From 1992-2015.
Incidence, Long-Term Outcomes, and Healthcare Utilization of Patients With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Disseminated Mycobacterium avium Complex From 1992-2015.
复制标题
DOI:
10.1093/ofid/ofx120
复制
发表时间:
2017
影响因子:
4.2
通讯作者:
Stout JE
中科院分区:
文献类型:
--
作者:
Collins LF;Clement ME;Stout JE
Despite the advent of combination antiretroviral therapy (cART), patients with human immunodeficiency virus (HIV) continue to develop late-stage complications including acquired immune deficiency syndrome (AIDS), disseminated Mycobacterium avium complex (DMAC), and death. We performed an observational retrospective cohort study of HIV-infected adults who developed DMAC in the Duke University Health System from 1992 to 2015 to determine the incidence, long-term outcomes, and healthcare utilization of this population at high risk for poor outcomes. Findings were stratified by the “pre-cART” era (before January 1, 1996) and “post-cART” thereafter. We identified 330 adult HIV-infected patients newly diagnosed with DMAC, the majority (75.2%) of whom were male and non-Hispanic black (69.1%), with median age of 37 years. Incidence of DMAC declined significantly from 65.3/1000 in 1992 to 2.0/1000 in 2015, and the proportion of females and non-Hispanic blacks was significantly higher in the post-cART era. The standardized mortality ratios for DMAC patients who received cART were 69, 58, 27, 5.9, and 6.8 at years 1–5, respectively, after DMAC diagnosis. For patients diagnosed with DMAC in 2000 or later (n = 135), 20% were newly diagnosed with HIV in the 3 months preceding presentation with DMAC. Those with established HIV had a median time from HIV diagnosis to DMAC diagnosis of 7 years and were more likely to be black, rehospitalized in the 6 months after DMAC diagnosis, and die in the long term. Disseminated Mycobacterium avium complex continues to be a lethal diagnosis in the cART era, disproportionately afflicts minority populations, and reflects both delayed entry into care and failure to consistently engage care.
登录
查看更多内容
影响因子:
3.7
作者:
Hall HI;Tang T;Westfall AO;Mugavero MJ
通讯作者:
Mugavero MJ
DOI:
10.1093/cid/ciu261
发表时间:
2014-07-15
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Ingle SM;May MT;Gill MJ;Mugavero MJ;Lewden C;Abgrall S;Fätkenheuer G;Reiss P;Saag MS;Manzardo C;Grabar S;Bruyand M;Moore D;Mocroft A;Sterling TR;D'Arminio Monforte A;Hernando V;Teira R;Guest J;Cavassini M;Crane HM;Sterne JA;Antiretroviral Therapy Cohort Collaboration
通讯作者:
Antiretroviral Therapy Cohort Collaboration
DOI:
10.1097/qai.0b013e3180517407
发表时间:
2007-06-01
影响因子:
3.6
作者:
Hellinger, Fred J.
通讯作者:
Hellinger, Fred J.
影响因子:
39.2
作者:
Althoff KN;Buchacz K;Hall HI;Zhang J;Hanna DB;Rebeiro P;Gange SJ;Moore RD;Kitahata MM;Gebo KA;Martin J;Justice AC;Horberg MA;Hogg RS;Sterling TR;Cescon A;Klein MB;Thorne JE;Crane HM;Mugavero MJ;Napravnik S;Kirk GD;Jacobson LP;Brooks JT;North American AIDS Cohort Collaboration on Research and Design
通讯作者:
North American AIDS Cohort Collaboration on Research and Design
影响因子:
6.4
作者:
Djawe, Kpandja;Buchacz, Kate;Schwarcz, Sandra
通讯作者:
Schwarcz, Sandra